Connection

HUDA ZOGHBI to Brain

This is a "connection" page, showing publications HUDA ZOGHBI has written about Brain.
Connection Strength

2.738
  1. Alpha-Synuclein Phosphomimetic Y39E and S129D Knock-In Mice Show Cytosolic Alpha-Synuclein Localization without Developing Neurodegeneration or Motor Deficits. eNeuro. 2025 Apr; 12(4).
    View in: PubMed
    Score: 0.382
  2. Rett syndrome: disruption of epigenetic control of postnatal neurological functions. Hum Mol Genet. 2015 Oct 15; 24(R1):R10-6.
    View in: PubMed
    Score: 0.193
  3. Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p. Genes Dev. 2013 Mar 01; 27(5):485-90.
    View in: PubMed
    Score: 0.165
  4. Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med. 2011 Jun 08; 3(86):86ra49.
    View in: PubMed
    Score: 0.147
  5. Neurogenetics: advancing the "next-generation" of brain research. Neuron. 2010 Oct 21; 68(2):165-73.
    View in: PubMed
    Score: 0.140
  6. The story of Rett syndrome: from clinic to neurobiology. Neuron. 2007 Nov 08; 56(3):422-37.
    View in: PubMed
    Score: 0.114
  7. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007; 30:575-621.
    View in: PubMed
    Score: 0.108
  8. Functional divergence of Capicua isoforms explains differential tissue vulnerability in neurological disease. Genes Dev. 2026 Aug 03; 40(15-16):1267-1282.
    View in: PubMed
    Score: 0.105
  9. MeCP2 interacts with the super elongation complex to regulate transcription. Sci Adv. 2025 11 28; 11(48):eadt5937.
    View in: PubMed
    Score: 0.100
  10. Postnatal neurodevelopmental disorders: meeting at the synapse? Science. 2003 Oct 31; 302(5646):826-30.
    View in: PubMed
    Score: 0.086
  11. Molecular neuroscience: BAC-to-BAC images of the brain. Nature. 2003 Oct 30; 425(6961):907-8.
    View in: PubMed
    Score: 0.086
  12. A novel pathogenic mutation of MeCP2 impairs chromatin association independent of protein levels. Genes Dev. 2023 10 01; 37(19-20):883-900.
    View in: PubMed
    Score: 0.086
  13. Evolutionarily conserved regulators of tau identify targets for new therapies. Neuron. 2023 03 15; 111(6):824-838.e7.
    View in: PubMed
    Score: 0.082
  14. Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am J Med Genet. 2002 Aug 01; 111(2):164-8.
    View in: PubMed
    Score: 0.079
  15. Proprioceptor pathway development is dependent on Math1. Neuron. 2001 May; 30(2):411-22.
    View in: PubMed
    Score: 0.073
  16. Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1. JCI Insight. 2021 02 08; 6(3).
    View in: PubMed
    Score: 0.072
  17. The distinct methylation landscape of maturing neurons and its role in Rett syndrome pathogenesis. Curr Opin Neurobiol. 2019 12; 59:180-188.
    View in: PubMed
    Score: 0.065
  18. Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription. Cell. 2019 08 22; 178(5):1159-1175.e17.
    View in: PubMed
    Score: 0.065
  19. Lessons learned from studying syndromic autism spectrum disorders. Nat Neurosci. 2016 10 26; 19(11):1408-1417.
    View in: PubMed
    Score: 0.053
  20. Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing Neurons in Mice Leads to Distinct Rett Syndrome-like Phenotypes. Neuron. 2015 Nov 18; 88(4):651-8.
    View in: PubMed
    Score: 0.050
  21. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat Genet. 1995 May; 10(1):94-8.
    View in: PubMed
    Score: 0.048
  22. Regional rescue of spinocerebellar ataxia type 1 phenotypes by 14-3-3epsilon haploinsufficiency in mice underscores complex pathogenicity in neurodegeneration. Proc Natl Acad Sci U S A. 2011 Feb 01; 108(5):2142-7.
    View in: PubMed
    Score: 0.036
  23. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature. 2010 Nov 11; 468(7321):263-9.
    View in: PubMed
    Score: 0.035
  24. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell. 2006 Dec 29; 127(7):1335-47.
    View in: PubMed
    Score: 0.027
  25. Generation and characterization of LANP/pp32 null mice. Mol Cell Biol. 2004 Apr; 24(8):3140-9.
    View in: PubMed
    Score: 0.022
  26. Mice lacking Tropomodulin-2 show enhanced long-term potentiation, hyperactivity, and deficits in learning and memory. Mol Cell Neurosci. 2003 May; 23(1):1-12.
    View in: PubMed
    Score: 0.021
  27. Decreasing mutant ATXN1 nuclear localization improves a spectrum of SCA1-like phenotypes and brain region transcriptomic profiles. Neuron. 2023 02 15; 111(4):493-507.e6.
    View in: PubMed
    Score: 0.020
  28. Scientific and technological synergy: Baylor College of Medicine and the Mental Retardation Research Center. Int J Dev Neurosci. 2002 Jun-Aug; 20(3-5):467-8.
    View in: PubMed
    Score: 0.020
  29. Disruption of MeCP2-TCF20 complex underlies distinct neurodevelopmental disorders. Proc Natl Acad Sci U S A. 2022 01 25; 119(4).
    View in: PubMed
    Score: 0.019
  30. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet. 2002 Jan 15; 11(2):115-24.
    View in: PubMed
    Score: 0.019
  31. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr Opin Neurol. 2001 Apr; 14(2):171-6.
    View in: PubMed
    Score: 0.018
  32. Spinocerebellar ataxias. Neurobiol Dis. 2000 Oct; 7(5):523-7.
    View in: PubMed
    Score: 0.017
  33. Coexpression enrichment analysis at the single-cell level reveals convergent defects in neural progenitor cells and their cell-type transitions in neurodevelopmental disorders. Genome Res. 2020 06; 30(6):835-848.
    View in: PubMed
    Score: 0.017
  34. Repeat instability and motor incoordination in mice with a targeted expanded CAG repeat in the Sca1 locus. Hum Mol Genet. 2000 Mar 22; 9(5):779-85.
    View in: PubMed
    Score: 0.017
  35. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci. 2000 Feb; 3(2):157-63.
    View in: PubMed
    Score: 0.017
  36. Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease. Hum Mol Genet. 2019 06 15; 28(12):2014-2029.
    View in: PubMed
    Score: 0.016
  37. Depleting Trim28 in adult mice is well tolerated and reduces levels of a-synuclein and tau. Elife. 2018 06 04; 7.
    View in: PubMed
    Score: 0.015
  38. Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. Cell. 2015 Mar 12; 160(6):1087-98.
    View in: PubMed
    Score: 0.012
  39. Chromosome assignment of human brain expressed sequence tags (ESTs) by analyzing fluorescently labeled PCR products from hybrid cell panels. Cytogenet Cell Genet. 1994; 65(1-2):86-91.
    View in: PubMed
    Score: 0.011
  40. Polyglutamine disease toxicity is regulated by Nemo-like kinase in spinocerebellar ataxia type 1. J Neurosci. 2013 May 29; 33(22):9328-36.
    View in: PubMed
    Score: 0.010
  41. Ataxin1L is a regulator of HSC function highlighting the utility of cross-tissue comparisons for gene discovery. PLoS Genet. 2013 Mar; 9(3):e1003359.
    View in: PubMed
    Score: 0.010
  42. Characterization of the zebrafish atxn1/axh gene family. J Neurogenet. 2009; 23(3):313-23.
    View in: PubMed
    Score: 0.008
  43. A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum Mol Genet. 2008 Jun 15; 17(12):1718-27.
    View in: PubMed
    Score: 0.007
  44. Neuropathology of Rett syndrome. Acta Neuropathol. 1988; 76(2):142-58.
    View in: PubMed
    Score: 0.007
  45. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum Mol Genet. 2007 Oct 01; 16(19):2315-25.
    View in: PubMed
    Score: 0.007
  46. Atypical presentation and neuropathological studies in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Ann Neurol. 1986 Sep; 20(3):367-9.
    View in: PubMed
    Score: 0.007
  47. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2000 Oct; 26(2):191-4.
    View in: PubMed
    Score: 0.004
  48. Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein. Hum Mol Genet. 2000 Sep 22; 9(15):2305-12.
    View in: PubMed
    Score: 0.004
  49. atonal regulates neurite arborization but does not act as a proneural gene in the Drosophila brain. Neuron. 2000 Mar; 25(3):549-61.
    View in: PubMed
    Score: 0.004
  50. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 1997 Oct 30; 389(6654):971-4.
    View in: PubMed
    Score: 0.004
  51. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann Neurol. 1994 Apr; 35(4):464-70.
    View in: PubMed
    Score: 0.003
  52. Rett's syndrome. Correlation of electroencephalographic characteristics with clinical staging. Arch Neurol. 1987 Oct; 44(10):1053-6.
    View in: PubMed
    Score: 0.002
  53. Rett syndrome: discrimination of typical and variant forms. Brain Dev. 1987; 9(5):458-61.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.